The partnership empowers patients to securely connect and collect their real-time medical records for clinical trials
SAN DIEGO — April 17, 2023 — At the HIMSS Global Health Conference, SEQSTER PDM Inc.
(“SEQSTER”), a pioneer in patient-centric healthcare data technology and patient management,
launched a partnership with CLEAR (NYSE: YOU), the trusted secure identity platform, to
provide patients with Individual Access Services and allow them to securely access, control and
share their personal health information with authorized users. SEQSTER has integrated the
CLEAR platform to allow patients to seamlessly confirm their identity, access their medical
records, and safely share them with various clinical trial research organizations within the
SEQSTER Operating System for healthcare.
With this partnership, patients can now affirm their identity – with just a government-issued ID
and a selfie – to easily create and manage their SEQSTER account. Once a SEQSTER patient
verifies their identity and creates their account, they can securely share their personal health
information with SEQSTER’s life sciences partners.
“Our partnership with CLEAR is a testament to our commitment to advancing healthcare
through innovative technologies and partnerships. With our combined expertise, we can make
real-world data more accessible, meaningful and impactful for patients, researchers, and
healthcare organizations,” said Ardy Arianpour CEO & Co-Founder at SEQSTER.
“The Powered by CLEAR platform makes it easy for patients to safely access and share their
health information in a matter of minutes,” said Caryn Seidman-Becker, CEO of CLEAR. “This
partnership means patients or clinical trial staff can spend more time focused on improving
health and less time making phone calls to track down health records. CLEAR is excited to be
working with SEQSTER to foster a more secure and less stressful patient clinical trial
"As a SEQSTER client, we know the value of real-world data in driving innovation and improving
patient outcomes. The partnership between SEQSTER and CLEAR is an exciting development
for the industry, and we're looking forward to working with SEQSTER to access faster, more
accurate data and ultimately deliver better treatments to patients," states Paul Petraro, Global
Head of Real World Evidence, Centre of Excellence for Boehringer Ingelheim.